Abstract
We have investigated twenty patients with suspicious breast lesions by fluorescence mammography using ICG as contrast agent. Differences in early and late fluorescence mammograms offer the chance to distinguish malignant from benign lesions.
© 2010 Optical Society of America
PDF ArticleMore Like This
C. H. Schmitz, S. Piper, P. Schneider, N. Volkwein, N. Schreiter, and A. Poellinger
BTuD101 Biomedical Optics (BIOMED) 2010
Leon Bakker, Martin van der Mark, Michiel van Beek, Marjolein van der Voort, Gert’t Hooft, Tim Nielsen, Thomas Koehler, Ronny Ziegler, Kai Licha, and Martin Pessel
SH56 Biomedical Topical Meeting (BIOMED) 2006
Michael A. Mastanduno, Scott C. Davis, Shudong Jiang, Roberta diFlorio-Alexander, Brian W. Pogue, and Keith D. Paulsen
80890A European Conference on Biomedical Optics (ECBO) 2011